This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Nov 1;171(11):1139-41.

doi: 10.1176/appi.ajp.2014.14081008.

Pharmacologic treatments for borderline personality disorder

Mauricio Tohen¹

Affiliations

PMID: 25756626
DOI: 10.1176/appi.ajp.2014.14081008

Editorial

Pharmacologic treatments for borderline personality disorder

Mauricio Tohen. Am J Psychiatry. 2014.

. 2014 Nov 1;171(11):1139-41.

doi: 10.1176/appi.ajp.2014.14081008.

Author

Mauricio Tohen¹

Affiliation

¹ From the Department of Psychiatry and Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque.

PMID: 25756626
DOI: 10.1176/appi.ajp.2014.14081008

No abstract available

PubMed Disclaimer

Comment on

Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial.
Black DW, Zanarini MC, Romine A, Shaw M, Allen J, Schulz SC. Black DW, et al. Am J Psychiatry. 2014 Nov 1;171(11):1174-82. doi: 10.1176/appi.ajp.2014.13101348. Am J Psychiatry. 2014. PMID: 24968985 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations